AMG 529 First in Human Study

NCT03170193 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular

Interventions

DRUG: AMG 529
DRUG: Placebo

Sponsor

Amgen